Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.4B | 3.4B | 2.9B | 2.9B |
Cost of revenue | 3.2B | 2.3B | 1.8B | 1.8B |
Gross profit | 1.2B | 1.2B | 1.1B | 1.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | 0 | 0 |
Other operating expenses | — | — | — | -20M |
Operating income | 623M | 670M | 517M | 522M |
Non operating interest income | ||||
Income | 23M | 34M | 48M | 36M |
Expense | 250M | 248M | 252M | 233M |
Other income expense | 31M | -134M | 43M | 33M |
Pretax income | 427M | 322M | 356M | 358M |
Tax provision | -18M | 30M | -121M | 36M |
Net income | 445M | 292M | 477M | 322M |
Basic EPS | 2.1 | — | 2.3 | 1.6 |
Diluted EPS | 2.1 | — | 2.3 | 1.6 |
Basic average shares | 207M | — | 207M | 207M |
Diluted average shares | 207M | — | 207M | 207M |
EBITDA | 1.1B | 1.1B | 1.0B | 1.0B |
Net income from continuing op. | 445M | 292M | 477M | 322M |
Minority interests | — | — | — | — |
Preferred stock dividends | 1M | — | 2M | 0 |